Indication:

Indicated as an adjunct to diet and exercise to improve glycemic control in patients with type-2 diabetes who are already treated with a combination of glimepiride and metformin or whose diabetes is not adequately controlled with metformin alone, or for those patients who have initially responded to glimepiride alone and require additional glycemic control.

Dosage & Administration:

Dosage should be individualized on the basis of both effectiveness and tolerance. The combination should be given once daily with meals and should be started at a low dose. The initial recommended dose is one tablet once daily with breakfast or first main meal of the day.

Preparation:

Spanbec^® M1 Tablet: Each box contains 10 x 10 tablets in blister pack.
Spanbec^® M2 Tablet: Each box contains 10 x 10 tablets in blister pack.